Ibere Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2020 – 2021)

2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
N/A92.5322.7192.53
Price/Sales ratio
N/AN/AN/AN/A
Price/Book Value ratio
N/A1.13-24.071.13
Price/Cash Flow ratio
N/A-166.35-205.71-166.35
Price/Free Cash Flow ratio
N/A-166.35-205.71-166.35
Price/Earnings Growth ratio
N/AN/A212.73N/A
Dividend Yield
N/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/A
Effective Tax Rate
N/A-1.09%N/AN/A
Return on Assets
N/A1.12%4.45%4.45%
Return On Equity
N/A1.22%6.43%6.43%
Return on Capital Employed
N/A-0.72%-0.74%-0.72%
Liquidity Ratios
Current Ratio
N/AN/A0.24N/A
Quick Ratio
0.261.860.001.86
Cash ratio
0.261.230.001.23
Days of Sales Outstanding
N/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.24N/A0.04N/A
Debt Equity Ratio
8.78N/A-1.01N/A
Long-term Debt to Capitalization
N/AN/AN/AN/A
Total Debt to Capitalization
0.89N/AN/AN/A
Interest Coverage Ratio
N/AN/A-10.73N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A
Company Equity Multiplier
35.151.09-23.811.09
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
N/A111
Cash Flow Coverage Ratio
N/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/A